Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00720980|
Recruitment Status : Completed
First Posted : July 23, 2008
Last Update Posted : July 23, 2008
|Condition or disease|
We will document the regimen treatment each patient has had and then review the following from the patient's chart to target our specific aims as outlined above.
- What previous treatment options have been or/are currently being used?
- How long did the patient take the treatment for?
- Was the patient able to discontinue or become less dependent on prior treatment?
- Was the disease process slowed by the treatment?;
- Were there any side effects that the patient experienced with treatment?
|Study Type :||Observational|
|Actual Enrollment :||6 participants|
|Official Title:||Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy|
|Study Start Date :||May 2008|
|Actual Primary Completion Date :||May 2008|
|Actual Study Completion Date :||July 2008|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00720980
|United States, Michigan|
|Henry Ford Medical Center|
|Detroit, Michigan, United States, 48202|
|Principal Investigator:||Iltefat H Hamzavi, MD||Henry Ford Health System|